Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 498296, 8 pages
http://dx.doi.org/10.1155/2013/498296
Research Article

Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls

1Division of Internal Medicine, Department of Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA
2Department of Pathology, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA
3Division of Gastroenterology, Department of Pediatrics, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA
4Division of Gastroenterology, Department of Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA
5Division of Epidemiology, Department of Family and Preventive Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA
6Liver Imaging Group, Department of Radiology, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA

Received 4 September 2013; Accepted 7 October 2013

Academic Editor: Gyorgy Baffy

Copyright © 2013 Niraj S. Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Clark, “The epidemiology of nonalcoholic fatty liver disease in adults,” Journal of Clinical Gastroenterology, vol. 40, supplement 1, pp. S5–S10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kotronen, M. Peltonen, A. Hakkarainen et al., “Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors,” Gastroenterology, vol. 137, no. 3, pp. 865–872, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Marchesini, E. Bugianesi, G. Forlani et al., “Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome,” Hepatology, vol. 37, no. 4, pp. 917–923, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Vernon, A. Baranova, and Z. M. Younossi, “Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 3, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. D. Williams, J. Stengel, M. I. Asike et al., “Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study,” Gastroenterology, vol. 140, no. 1, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni, “Epidemiology of non-alcoholic fatty liver disease,” Digestive Diseases, vol. 28, no. 1, pp. 155–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Bhala, P. Angulo, D. van der Poorten et al., “The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study,” Hepatology, vol. 54, no. 4, pp. 1208–1216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. A. Pitt, “Hepato-pancreato-biliary fat: the good, the bad and the ugly,” HPB, vol. 9, no. 2, pp. 92–97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. C. Wu and C. Y. Wang, “Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case—control retrospective study,” Cardiovasc Diabetol, vol. 12, article 77, 2013. View at Publisher · View at Google Scholar
  11. M. Al-Haddad, M. Khashab, N. Zyromski et al., “Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study,” Pancreas, vol. 38, no. 6, pp. 672–675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. S. Lee, S. H. Kim, D. W. Jun et al., “Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome,” World Journal of Gastroenterology, vol. 15, no. 15, pp. 1869–1875, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. Sepe, A. Ohri, S. Sanaka et al., “A prospective evaluation of fatty pancreas by using EUS,” Gastrointestinal Endoscopy, vol. 73, no. 5, pp. 987–993, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. E. Sijens, M. A. Edens, S. J. L. Bakker, and R. P. Stolk, “MRI-determined fat content of human liver, pancreas and kidney,” World Journal of Gastroenterology, vol. 16, no. 16, pp. 1993–1998, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. W. Choi, G. H. Kim, D. H. Kang et al., “Associated factors for a hyperechogenic pancreas on endoscopic ultrasound,” World Journal of Gastroenterology, vol. 16, no. 34, pp. 4329–4334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. S. Patel, M. R. Peterson, D. A. Brenner et al., “Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease,” Alimentary Pharmacology & Therapeutics, vol. 37, no. 6, pp. 630–639, 2013. View at Publisher · View at Google Scholar
  17. C. D. G. Hines, A. Frydrychowicz, G. Hamilton et al., “T1 independent, T2* corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis,” Journal of Magnetic Resonance Imaging, vol. 33, no. 4, pp. 873–881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. L. S. Szczepaniak, P. Nurenberg, D. Leonard et al., “Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population,” American Journal of Physiology: Endocrinology and Metabolism, vol. 288, no. 2, pp. E462–E468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Permutt, T.-A. Le, M. R. Peterson et al., “Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD,” Alimentary Pharmacology and Therapeutics, vol. 36, pp. 22–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Noureddin, J. Lam, M. R. Peterson et al., “Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial,” Hepatology, 2013. View at Publisher · View at Google Scholar
  22. T. Yokoo, M. Bydder, G. Hamilton et al., “Nonalcoholic fatty liver disease: Diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T,” Radiology, vol. 251, no. 1, pp. 67–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yokoo, M. Shiehmorteza, G. Hamilton et al., “Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T,” Radiology, vol. 258, no. 3, pp. 749–759, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. T. A. Le, J. Chen, C. Changchien et al., “Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial,” Hepatology, vol. 56, no. 3, pp. 922–932, 2012. View at Publisher · View at Google Scholar
  25. N. F. Schwenzer, J. Machann, P. Martirosian et al., “Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques,” Investigative Radiology, vol. 43, no. 5, pp. 330–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. H. Kang, I. Cruite, M. Shiehmorteza et al., “Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms,” Journal of Magnetic Resonance Imaging, vol. 34, no. 4, pp. 928–934, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Loomba, S.-J. Hwang, C. J. O'Donnell et al., “Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham Heart study,” Gastroenterology, vol. 134, no. 4, pp. 953.e1–959.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Loomba, F. Rao, L. Zhang et al., “Genetic covariance between γ-glutamyl transpeptidase and fatty liver risk factors: role of β2-adrenergic receptor genetic variation in twins,” Gastroenterology, vol. 139, no. 3, pp. 836.e1–845.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. T. S. Olsen and I. P. G. H. C. Inst. pathol. Glostrup Hosp. Copenhagen, “Lipomatosis of the pancreas in autopsy material and its relation to age and overweight,” Acta Pathologica et Microbiologica Scandinavica A, vol. 86, no. 5, pp. 367–373, 1978. View at Google Scholar · View at Scopus
  30. B. H. Stamm, “Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease,” Human Pathology, vol. 15, no. 7, pp. 677–683, 1984. View at Google Scholar · View at Scopus
  31. E.-J. M. van Geenen, M. M. Smits, T. C. M. A. Schreuder, D. L. van der Peet, E. Bloemena, and C. J. J. Mulder, “Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease,” Pancreas, vol. 39, no. 8, pp. 1185–1190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Y. Ou, C. Y. Wang, Y. C. Yang et al., “The association between nonalcoholic fatty pancreas disease and diabetes,” PLoS One, vol. 8, Article ID e62561, 2013. View at Publisher · View at Google Scholar
  33. J. Li, Y. Xie, F. Yuan, B. Song, and C. Tang, “Noninvasive quantification of pancreatic fat in healthy male population using chemical shift magnetic resonance imaging: effect of aging on pancreatic fat content,” Pancreas, vol. 40, no. 2, pp. 295–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Targher, A. P. Rossi, G. A. Zamboni et al., “Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals,” Journal of Endocrinological Investigation, vol. 35, pp. 748–753, 2012. View at Google Scholar
  35. J. B. Dixon, P. S. Bhathal, and P. E. O'Brien, “Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese,” Gastroenterology, vol. 121, no. 1, pp. 91–100, 2001. View at Google Scholar · View at Scopus
  36. A. L. F. D. A. Salgado, L. de Carvalho, A. C. Oliveira, V. N. dos Santos, J. G. Vieira, and E. R. Parise, “Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals,” Arquivos de Gastroenterologia, vol. 47, no. 2, pp. 165–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. B. A. Neuschwander-Tetri, J. M. Clark, N. M. Bass et al., “Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease,” Hepatology, vol. 52, no. 3, pp. 913–924, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Loomba, M. Abraham, A. Unalp et al., “Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis,” Hepatology, vol. 56, no. 3, pp. 943–951, 2012. View at Publisher · View at Google Scholar
  39. R. Pais, F. Charlotte, L. Fedchuk et al., “A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver,” Journal of Hepatology, vol. 59, no. 3, pp. 550–556, 2013. View at Publisher · View at Google Scholar
  40. I. Doycheva, N. Patel, M. Peterson, and R. Loomba, “Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes,” Journal of Diabetes and Its Complications, vol. 27, no. 3, pp. 293–300, 2013. View at Publisher · View at Google Scholar
  41. M. Heni, J. Machann, H. Staiger et al., “Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 200–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. E. Tushuizen, M. C. Bunck, P. F. Pouwels et al., “Pancreatic fat content and beta;-cell function in men with and without type 2 diabetes,” Diabetes Care, vol. 30, pp. 2916–2921, 2007. View at Google Scholar
  43. G. Musso, M. Cassader, F. De Michieli, F. Rosina, F. Orlandi, and R. Gambino, “Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism,” Hepatology, vol. 56, no. 3, pp. 933–942, 2012. View at Publisher · View at Google Scholar
  44. A. B. R. Maggio, P. Mueller, J. Wacker et al., “Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome,” Journal of Pediatric Gastroenterology and Nutrition, vol. 54, pp. 720–726, 2012. View at Publisher · View at Google Scholar · View at Scopus